Fundraising Fox

Chris Ehrlich

Interim Chairman and CEO at Cero Therapeutics Holdings

San Francisco, California, United States

Find your path to Chris

206 people in our graph share verified history with Chris — schools, employers, funds. One of them is your warm intro.

Ren RileyunlockedChris: together at Dartmouth College (1992)
×4Chris: together at Dartmouth College
×6Chris: together at Northwestern University - Kellogg School of Management
Chris: together at University of San Francisco

Interim Chairman and CEO at Cero Therapeutics Holdings

Experience

  1. Geisel School of Medicine at DartmouthMember of the Board of Advisorscurrent2025 — presentHanover, New Hampshire, United States
  2. University of San FranciscoAdvisory Board Member, Entrepreneurship and Innovation Programcurrent2025 — present
  3. University of San FranciscoAdjunct Professorcurrent2025 — present
  4. CERo Therapeutics, Inc.Chief Executive Officercurrent2024 — presentSouth San Francisco, California, United States
  5. CERo Therapeutics, Inc.Vice Chair2024South San Francisco, Ca
  6. Launch One Acquisition CorpChief Executive Officercurrent2024 — presentUnited States
  7. Espervita TherapeuticsSenior Advisorcurrent2024 — present
  8. AltiibioSenior Business Advisorcurrent2023 — presentHalf Moon Bay, California, United States
  9. Dimension InxSenior Business Advisorcurrent2023 — present
  10. Health Care at Kellogg Advisory BoardAdvisorcurrent2019 — presentEvanston, Illinois, United States
  11. PMDIBoard Membercurrent2012 — presentSt Louis, Missouri, United States
  12. Peter Michael FoundationSenior Advisorcurrent2010 — presentSan Francisco Bay Area
  13. eFFECTOR Therapeutics, Inc.Director2021 — 2024
  14. Phoenix Biotech Acquisition Corp.Chief Executive Officer2021 — 2024San Francisco, California, United States
  15. ProlynxBoard Member2022 — 2023San Francisco Bay Area
  16. Locust Walk Acquisition CorpChief Executive Officer2021
  17. Locust WalkSenior Managing Director2013 — 2021San Francisco Bay Area
  18. InterWest PartnersManaging Director2000 — 2013
  19. Purdue Pharma L.P.Director1998 — 2000
  20. GenentechBusiness Development Manager1997South San Francisco
  21. The U.S. Russia Investment FundAssociate1994 — 1996New York, NY
  22. L.E.K. ConsultingAssociate1992 — 1994Greater Boston Area

Skills & more

Corporate Development15Venture Capital29Mergers & Acquisitions9Start-ups33Strategy13Business Strategy5Business Development8Angel Investing2Entrepreneurship7Strategic Partnerships5Executive Management5Private Equity6
+8 moreMarketing StrategyInvestmentsDue DiligenceGo-to-market StrategyProduct ManagementSaaSLicensingEmerging Markets

Languages French

From Chris's professional profile.

Frequently asked questions

Who is Chris Ehrlich?
Interim Chairman and CEO at Cero Therapeutics Holdings
Where does Chris Ehrlich work?
Chris Ehrlich is Interim Chairman and CEO at Cero Therapeutics Holdings.
Where did Chris Ehrlich go to school?
Chris Ehrlich studied at Northwestern University - Kellogg School of Management (Master of Business Administration (MBA)); Dartmouth College (Bachelor's degree, Political Science and Government).

Same school

Also attended Northwestern University - Kellogg School of Management913

Jenny LeeSenior Managing Partner at Granite AsiaKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalCristina JunqueiraCo-founder of NubankAndy FligelSenior Managing Director at Intel CapitalDavid Clark GuillermoInvestments at Impact America FundGiuseppe DonvitoPartner at P101 Ventures

+ 907 more

Also attended Dartmouth College598

Scott SandellExecutive Chairman & Chief Investment Officer at NEAJames DetweilerVP of Investments at Felicis VenturesBen RobbinsInvestor at GV (Google Ventures)Mounisha AnumoluInvestor at GV (Google Ventures)Ren RileyAdvisor at Oak Investment PartnersJeffrey PaineFounding Partner at Golden Gate Ventures

+ 592 more

Shared employers

Also worked at Geisel School of Medicine at Dartmouth7

Russ RapaportAssociate at 1315 CapitalEricka Tamayo-GuevaraAnalyst at The Engine VenturesPrachee AvasthiHead of Open Science at Astera InstituteRachel GarlickFounder at Eris BiotechWarren ShepardFounder at Control SeatIshan RamrakhianiFounder at Shepherd

+ 1 more

Also worked at Dimension Inx6

Justin BriggsScientist, entrepreneur, and investor building companies at the nexus of biology, chemistry, and engineeringPhil GrayeskiManaging Partner at KdT VenturesTravis ManascoPrincipal at Solas BioVenturesIsaiah ReevesAnalyst at Solas BioVenturesCaralynn Nowinski Collens, M.D.Co-founder & CEO at Dimension InxAdam JakusCo-Founder at Dimension Bio

Also worked at Prolynx5

Kush M ParmarManaging Partner at 5AM VenturesMax FarinaPrincipal at 5AM VenturesKori RahaimSenior Vice President, Head of People and 4:59 Initiative Business Operations at 5AM VenturesSebastian BernalesGeneral Partner at HumboldtRICHARD KINGExecutive Officer, Director at Spruce Biosciences

Also worked at Genentech204

David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures

+ 198 more